RxDoctor Payments Data

Charles Morelli, DPM

Foot Surgery · Mamaroneck, NYNPI 1992703847

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (54.4%), education and charitable contributions — rather than concentrated in one kind of arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 20.9%. Reporting peaked in 2019 at $3,934 and has fallen 71.6% since, to $1,117 in 2025. Among foot surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,102in general payments, 2019–2025

Across 145 payments — averaging $124.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paragon 28, Inc.$4K
  • Gotham Surgical Solutions & Devices, Inc.$3K
  • Arthrex$2K
  • Treace Medical Concepts, Inc.$2K
  • Paratek Pharmaceuticals, Inc.$1K
  • Smith+Nephew$1K
  • plus $5K from 21 others

What the payments were for

  • Travel & lodging$1,93711%
  • Food & beverage$9,85554%
  • Education$4,07623%
  • Charitable contribution$2,23412%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,102 in reported general payments places this provider in the 95th percentile of 294 foot surgery providers in New York.

See all foot surgery providers in New York

Medicare billing

Part B allowed, 2024
$114,861
Medicare patients
398
Services billed
1,638

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Allopurinol57$681
Betamethasone Dipropionate11$559
Gabapentin33$350
Terbinafine Hcl42$272
Meloxicam13$78

Paid to pharmacies, not to this prescriber.

Other foot surgery in Mamaroneck

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →